Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

NTLANTLA

Showing 8 of 11 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in Intellia Therapeutics, Inc.

Yes. Brevan Howard Capital Management holds 77,951 shares of NTLA (Intellia Therapeutics), worth $1.3M, as of its Q2 2026 13F filing. It increased the position by 4,028 shares (+5.5%) from Q1 2026. Brevan Howard Capital Management has held NTLA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.3M

Current Shares

77,951

Total Value Change

+$1M

Total Shares Change

+63,033

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
77,951
+5.5%
$1.3M0.0%$16.92
27
2026-Q1
Increased
73,923
+386.3%
$947,6930.0%$12.82
40
2025-Q4
Decreased
15,202
-76.3%
$136,6660.0%$8.99
0
2025-Q3
Increased
64,154
+190.3%
$1.1M0.0%$17.27
41
2025-Q2
New
22,097
—
$207,2700.0%$9.38
32
2025-Q1
Exited
0
-100.0%
$00.0%$7.11
0
2024-Q4
Increased
108,351
+626.3%
$1.3M0.0%$11.66
41
2024-Q3
New
14,918
—
$306,5650.0%$20.55
32

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used